Plasma Fractionation Market Global Opportunities, Industry Analysis, Size, Share, Demand, Growth, and Forecast 2026

1
Plasma Fractionation Market Size, Share
Industry Analysis, By Product Type (Albumin,
Immunoglobulin (Intravenous Immunoglobulin and
Subcutaneous Immunoglobulin), Coagulation
Factors, Protease Inhibitors and Others), By
Application (Immunology Neurology, Hematology,
Critical Care, Pulmonology and Others), By End
User (Hospitals Clinics,), and Geography
Forecast 2019-2026
Buy Now
Sample PDF
Get Discount
Published Date April 2019 Report Format PDF
Region Global Base Year 2018
2
Plasma Fractionation Market Size, Share
Industry Analysis, By Product Type (Albumin,
Immunoglobulin (Intravenous Immunoglobulin and
Subcutaneous Immunoglobulin), Coagulation
Factors, Protease Inhibitors and Others), By
Application (Immunology Neurology, Hematology,
Critical Care, Pulmonology and Others), By End
User (Hospitals Clinics,), and Geography
Forecast 2019-2026
Report Highlights The increasing prevalence of
respiratory diseases and alpha-1 antitrypsin
deficiency among people worldwide is boosting the
global plasma fractionation market, says Fortune
Business Insights in a new study. The report,
titled Plasma Fractionation Global Market
Analysis, Insights, and Forecasts 2018 to 2026,
offers insights into growth drivers and
restraints impacting the plasma fractionation
market. According to the report, the global
market for plasma fractionation is estimated to
rise at a CAGR of 6.2 and reach a value of US
38,652.1 Mn by 2026 from US 24,078.5 Mn in 2018.
In terms of product, the market is anticipated to
be dominated by the immunoglobulin segment as
they play a major role in detecting and
destroying the bacteria present in the body. In
the year 2018, immunoglobulin segment accounted
for about 47.7 share in the global market. On
the other side, the protease inhibitors segment
is anticipated to exhibit the growth at the
fastest rate. This is attributable to the fact
that protease inhibitors are used as antiviral
agents and help to prevent infection. In addition
to that, the use of these inhibitors for HIV is
anticipated to drive the over the forecast
period.
3
Plasma Fractionation Market Size, Share
Industry Analysis, By Product Type (Albumin,
Immunoglobulin (Intravenous Immunoglobulin and
Subcutaneous Immunoglobulin), Coagulation
Factors, Protease Inhibitors and Others), By
Application (Immunology Neurology, Hematology,
Critical Care, Pulmonology and Others), By End
User (Hospitals Clinics,), and Geography
Forecast 2019-2026
Rise in Number of Diagnostic Centers for using
Plasma Proteins as Therapeutics to Bode Well for
Market The rising awareness about diseases
because of the expansion of media and increasing
number of diagnostic centers have increased the
value of plasma fractionation. This is a major
factor boosting the overall market. In addition
to that, increasing investments made in designing
of therapeutics for chronic diseases is also
anticipated to drive the global market. Besides
this, the increasing popularity and usage of
proteins derived from plasma for various
treatments is presumed to bode well for the
global market. North America Emerges Dominant on
Account of Better Healthcare Infrastructures
Geographically, the global market for plasma
fractionation is dominated by North America at
present. Factors promoting growth in this region
are better healthcare infrastructures, government
supported reimbursement policies, and presence of
large company in developed nations of the region
namely Canada and the U.S. Moreover, recent
approvals from the Food and Drug (FDA) favor the
growth of new plasma fractionation facilities are
thus creating lucrative growth opportunities for
the market in North America. Browse Complete
Report Details https//www.fortunebusinessinsight
s.com/industry-reports/plasma-fractionation-market
-101614
4
Plasma Fractionation Market Size, Share
Industry Analysis, By Product Type (Albumin,
Immunoglobulin (Intravenous Immunoglobulin and
Subcutaneous Immunoglobulin), Coagulation
Factors, Protease Inhibitors and Others), By
Application (Immunology Neurology, Hematology,
Critical Care, Pulmonology and Others), By End
User (Hospitals Clinics,), and Geography
Forecast 2019-2026

• List of the companies functioning in the global
  market are
• LFB
• Shire
• Japan Blood Products Organization
• Biotest AG
• Grifols, S.A.
• G.C. Pharma (Green Cross Corporation)
• Octapharma
• Sanquin
• Kedrion S.p.A.
• Baxter
• China Biologic Products
• CSL
• Shanghai RAAS Blood Products
• Get Customization
• https//www.fortunebusinessinsights.com/enquiry/sp
  eak-to-analyst/plasma-fractionation-market-101614
•  

5
Plasma Fractionation Market Size, Share
Industry Analysis, By Product Type (Albumin,
Immunoglobulin (Intravenous Immunoglobulin and
Subcutaneous Immunoglobulin), Coagulation
Factors, Protease Inhibitors and Others), By
Application (Immunology Neurology, Hematology,
Critical Care, Pulmonology and Others), By End
User (Hospitals Clinics,), and Geography
Forecast 2019-2026
About Us Fortune Business Insights offers expert
corporate analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them to address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence, giving
a granular overview of the market they are
operating in.    Our reports contain a unique mix
of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our
team of experienced analysts and consultants use
industry-leading research tools and techniques to
compile comprehensive market studies,
interspersed with relevant data.    Phone US 1
424 253 0390 UK 44 2071 939123 APAC 91 744
740 1245 Email sales_at_fortunebusinessinsights.com